Fundz

Firefly Neuroscience acquires Evoke Neuroscience

PUBLIC · AIFFMay 05, 2025

Acquiring Company

Firefly Neuroscience

Acquired Company

Evoke Neuroscience

KenmoreNew YorkInformation TechnologyHardwareHealth CareBiotechnologyHealth CareMedical

Description

Firefly Neuroscience, Inc. has acquired Evoke Neuroscience, Inc. for $6 million, with the payment split between cash and stock. This acquisition will significantly expand Firefly's database and technology portfolio in brain health assessment. The deal is expected to enhance both companies' capabilities and drive future growth. Evoke's investors may also receive an earn-out based on revenue targets.

Quick answer

Firefly Neuroscience is acquiring Evoke Neuroscience, announced May 5, 2025. Firefly Neuroscience is based in Kenmore, New York, United States.

How much did Firefly Neuroscience pay for Evoke Neuroscience?
The deal value was not disclosed.
What does Firefly Neuroscience do?
Firefly Neuroscience, Inc. was fomerly known as Wavedancer.
Where are Firefly Neuroscience and Evoke Neuroscience based?
Firefly Neuroscience is based in Kenmore, New York, United States. Evoke Neuroscience is based in New York, New York, United States.
Who are the decision-makers at Firefly Neuroscience?
Fundz holds 1 contact at Firefly Neuroscience. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Hardware and Medical

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Firefly Neuroscience, and when

When Firefly Neuroscience changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Firefly Neuroscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Firefly Neuroscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Firefly Neuroscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Firefly Neuroscience

Location

Kenmore, New York, United States

About

Firefly Neuroscience, Inc. was fomerly known as Wavedancer. Firefly is an AI company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Firefly’s FDA-510(k) cleared Brain Network Analytics (BNA™) technology revolutionizes diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has built a comprehensive database of brain wave tests, secured patent protection, and achieved FDA clearance. The Company is now launching BNA™ commercially, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Firefly Neuroscience makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Gil
Likely contact at this company
••••••••@••••••••

See Gil's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Firefly Neuroscience's next move

Learn about Strategic plan

Frequently asked

Who acquired Evoke Neuroscience?

Evoke Neuroscience was acquired by Firefly Neuroscience, based in Kenmore. The deal was reported on May 5, 2025. Firefly Neuroscience, Inc. was fomerly known as Wavedancer. Firefly is an AI company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Firefly Neuroscience is publicly traded (AIFF) and operates in Information Technology.

When did Firefly Neuroscience acquire Evoke Neuroscience?

Firefly Neuroscience's acquisition of Evoke Neuroscience was reported on May 5, 2025. Firefly Neuroscience, Inc. has acquired Evoke Neuroscience, Inc. for $6 million, with the payment split between cash and stock. This acquisition will significantly expand Firefly's database and technology portfolio in brain health assessment. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Evoke Neuroscience do?

Evoke Neuroscience is a medical device company specializing in brain health assessment technologies. It focuses on the development and commercialization of methods to aid in brain health diagnosis. It is privately held, operating in Biotechnology, and is based in New York.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.